← Leaderboards
Deborah W Knapp
Purdue University West Lafayette
$3,970,345
Attributed
$3,970,345
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $672.3K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,970,345 · 4
By mechanism
U01$3,192,614 · 2
R21$612,906 · 1
P30$164,825 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- Stephen F. Badylak$11,773,649
- Cynthia Vianne Stauffacher$3,361,342
- David H Thompson$5,071,013
Others in their field
Top investigators on “Universities”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$507,483,583
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$463,124,587
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
UniversitiesCanis FamiliarisCellsMolecularComparativeMalignant Neoplasm Of Urinary BladderMalignant NeoplasmsNci Center For Cancer ResearchClinicBaseTransitional Cell CarcinomaPre-ClinicalNeoplasm /Cancer InvasivenessBasic ScienceAntineoplastic AgentsAwardIn VitroIn VivoIn Vivo ModelFacultyEvaluationCancer Center Support GrantAnti-Cancer TherapeuticExtramural Activities
Grant awards (16)
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer$672,254
U01 · FY2025 · CA · contact PI
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer$485,357
U01 · FY2024 · CA · contact PI
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer$552,535
U01 · FY2023 · CA · contact PI
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer$563,811
U01 · FY2022 · CA · contact PI
Medicinal Chemistry Research Program (Project-003)$34,948
P30 · FY2019 · CA · contact PI
Medicinal Chemistry Research Program (Project-003)$34,087
P30 · FY2018 · CA · contact PI
Medicinal Chemistry Research Program (Project-003)$7,467
P30 · FY2018 · CA · contact PI
Medicinal Chemistry Research Program (Project-003)$28,393
P30 · FY2017 · CA · contact PI
Medicinal Chemistry Research Program (Project-003)$33,281
P30 · FY2016 · CA · contact PI
Medicinal Chemistry Research Program (Project-003)$26,649
P30 · FY2015 · CA · contact PI
Targeted Intervention Against EphA2 on Cancer Cells$239,945
U01 · FY2004 · CA
Targeted Intervention Against EphA2 on Cancer Cells$232,955
U01 · FY2003 · CA
Pilot Study--Cox2 Inhibitor in Invasive Bladder Cancer$299,561
R21 · FY2002 · CA
Targeted Intervention Against EphA2 on Cancer Cells$226,173
U01 · FY2002 · CA
Pilot Study--Cox2 Inhibitor in Invasive Bladder Cancer$313,345
R21 · FY2001 · CA
Targeted Intervention Against EphA2 on Cancer Cells$219,584
U01 · FY2001 · CA